Kleanthis G. Xanthopoulos, Ph.D.

Dr. Xanthopoulos has over  24 years of experience in the biotechnology and pharmaceutical research industries as an executive, company founder, chief executive officer, investor and board member. Dr. Xanthopoulos is currently Chairman & CEO of Shoreline Biosciences, and Chairman of Stork Capital Life Sciences, which focuses on building and investing in innovative biotechnology companies. He serves on a number of private and public boards. Dr. Xanthopoulos received a B.S. in Biology from Aristotle University of Thessaloniki, Greece, and both a M.Sc. in Microbiology and a Ph.D. in Molecular Biology from the University of Stockholm, Sweden.